These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36539463)

  • 21. Predictors of the effects of smoking cessation on the endothelial function of conduit and digital vessels.
    Fukumoto K; Takemoto Y; Norioka N; Takahashi K; Namikawa H; Tochino Y; Shintani A; Yoshiyama M; Shuto T
    Hypertens Res; 2021 Jan; 44(1):63-70. PubMed ID: 32694770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
    Duan X; Ling F
    Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
    Bove M; Cicero AF; Veronesi M; Borghi C
    Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricemia and endothelial function: From molecular background to clinical perspectives.
    Maruhashi T; Hisatome I; Kihara Y; Higashi Y
    Atherosclerosis; 2018 Nov; 278():226-231. PubMed ID: 30326405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients.
    Cicero AFG; Fogacci F; Cincione RI; Tocci G; Borghi C
    Med Princ Pract; 2021; 30(2):122-130. PubMed ID: 33040063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.
    Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between serum uric acid level and vascular injury markers in hemodialysis patients.
    Harada M; Fujii K; Yamada Y; Tsukada W; Tsukada M; Hashimoto K; Kamijo Y
    Int Urol Nephrol; 2020 Aug; 52(8):1581-1591. PubMed ID: 32557375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia.
    Matsuo H; Ishikawa E; Machida H; Mizutani Y; Tanoue A; Ohnishi T; Murata T; Okamoto S; Ogura T; Nishimura Y; Ito H; Yasutomi M; Katayama K; Nomura S; Ito M
    Clin Exp Nephrol; 2020 Apr; 24(4):307-313. PubMed ID: 31845065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.
    Dogan A; Yarlioglues M; Kaya MG; Karadag Z; Dogan S; Ardic I; Dogdu O; Kilinc Y; Zencir C; Akpek M; Ozdogru I; Oguzhan A; Kalay N
    Blood Press; 2011 Jun; 20(3):182-7. PubMed ID: 21133824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
    Alshahawey M; Shahin SM; Elsaid TW; Sabri NA
    Am J Nephrol; 2017; 45(5):452-459. PubMed ID: 28463849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
    Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
    J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.
    Tanaka K; Nakayama M; Kanno M; Kimura H; Watanabe K; Tani Y; Hayashi Y; Asahi K; Terawaki H; Watanabe T
    Clin Exp Nephrol; 2015 Dec; 19(6):1044-53. PubMed ID: 25676011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Uric Acid Levels are Associated with Cardiometabolic Risk Factors in Healthy Young and Middle-Aged Adults.
    Ferreira TDS; Fernandes JFR; Araújo LDS; Nogueira LP; Leal PM; Antunes VP; Rodrigues MLG; Valença DCT; Kaiser SE; Klein MRST
    Arq Bras Cardiol; 2018 Dec; 111(6):833-840. PubMed ID: 30328946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials.
    Xin W; Mi S; Lin Z
    Cardiovasc Ther; 2016 Dec; 34(6):441-449. PubMed ID: 27542348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study.
    Kaneko T; Miyazaki S; Kurita A; Morimoto R; Tsuchiya S; Watanabe N; Takaku T; Komatsu N; Minamino T
    Cardiooncology; 2023 Feb; 9(1):11. PubMed ID: 36814340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study.
    Misra D; Zhu Y; Zhang Y; Choi HK
    Semin Arthritis Rheum; 2011 Dec; 41(3):471-6. PubMed ID: 21435695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperuricemia induces endothelial dysfunction.
    Khosla UM; Zharikov S; Finch JL; Nakagawa T; Roncal C; Mu W; Krotova K; Block ER; Prabhakar S; Johnson RJ
    Kidney Int; 2005 May; 67(5):1739-42. PubMed ID: 15840020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.